Former Boston Beer CEO Martin Roper Sold $2.5M of Vita Coco After COCO's 52-Week Surge

Martin Roper sold roughly $2.52 million of Vita Coco stock on April 7-8 after exercising 50,000 low-strike options at $10.178 per share. The timing matters because COCO had just come off a sharp post-earnings run that pushed the stock to a 52-week high in March, turning a routine compensation event into a well-timed liquidity move.

One important correction to the raw insider-profile framing: Roper is not Boston Beer's current CEO. He ran Boston Beer from 2001 to 2018, while Vita Coco's investor-relations site lists him as the company's current CEO and Boston Beer said in August 2025 that founder Jim Koch returned to the CEO role. That makes this filing more relevant to COCO holders than to SAM holders, even though Roper's long Form 4 history still ties him closely to Boston Beer.

Transaction breakdown

Date	Code	Security	Shares	Price	Estimated value
2026-04-07	M	COCO	25,000	$10.178	$254,450 exercise cost
2026-04-07	S	COCO	25,000	$50.00	$1,250,000 proceeds
2026-04-08	M	COCO	25,000	$10.178	$254,450 exercise cost
2026-04-08	S	COCO	25,000	$50.949	$1,273,725 proceeds

Gross sale proceeds came to about $2.52 million, while the combined exercise cost was just under $509,000. In other words, Roper used a two-day window near $50 a share to crystallize roughly $2.01 million of intrinsic option value.

Why this sale stands out now

Vita Coco had given executives a strong tape to sell into. The company reported full-year 2025 net sales of $610 million on February 18, up 18% year over year, with Vita Coco Coconut Water sales up 26% for the full year. Management also guided for 2026 net sales of $680 million to $700 million and adjusted EBITDA of $122 million to $128 million, reinforcing the market's view that COCO is still one of the faster-growing names in beverages.

That backdrop helps explain why an exercise-and-sell at about $50 does not read like distress selling. COCO had traded as high as $61.39 in March before pulling back into the high-$40s by early April, so Roper was still monetizing options at nearly five times the $10.178 strike price even after the stock cooled off. On the earnings call, management said a Walmart reset was adding 5% to 6% to total scans, another sign that the brand's distribution story was still working.

The bigger picture is that public markets have recently rewarded growth beverage stories more than mature alcohol names. Investors watching SAM, TAP, and STZ have spent the last year debating category fatigue and mix shifts, while global drink giants like KO and PEP trade on scale and resilience. COCO sits in a different bucket: smaller, faster, and more sensitive to execution around distribution, pricing, and category momentum.

Ownership context: what the filing says after the sale

The April filing does not show a full exit. Form 4 Table I listed 298,484 common shares after the April 8 sale, and the derivative section still showed 529,670 securities remaining after the option exercise activity. That is why this should be read as monetization, not abandonment.

Roper's broader insider record is unusually deep because his career spans multiple beverage and consumer boards, including MGP Ingredients. 13F Insight's profile logs 2,955 insider transactions and about $283.6 million of career sales, most of them tied to Boston Beer rather than Vita Coco.

For Boston Beer itself, beneficial ownership remains concentrated even without Roper in management. The latest 13D/G filings show founder C. James Koch at 21.62%, Vanguard at 12.09%, and AQR Capital Management at 5.12% in SAM. That matters because Roper's name still carries Boston Beer SEO value, but the capital-markets signal in this filing is overwhelmingly about COCO.

Key facts

Metric	Value
Insider	Martin Roper
Current operating role	Chief Executive Officer of Vita Coco
Boston Beer link	Former CEO of Boston Beer from 2001 to 2018
Recent transaction pattern	Two-day exercise-and-sell in COCO
Shares sold	50,000
Average sale price	About $50.47
Estimated gross proceeds	About $2.52 million
Exercise price	$10.178 per share
Common shares after latest sale	298,484 per Form 4 Table I
Derivative securities after latest exercise activity	529,670 per Form 4 Table II
Career insider transactions	2,955
Career sales tracked by 13F Insight	$283.6 million

What to watch next

• COCO Q1 results in late April — management already told investors to expect the next update in late April, so the key question is whether scan momentum and private-label recovery are still supporting the $680 million to $700 million full-year sales target.
• COCO versus its March high — if shares reclaim the $61 area, future option exercises by Roper or other executives would look more like disciplined profit-taking than a warning sign.
• Remaining low-strike equity — the filing still showed substantial derivative exposure after this two-day sale, so investors should watch whether Roper keeps using strength to reduce that overhang in measured pieces.
• SAM ownership filings — Boston Beer remains tightly held, and any new amendment from Jim Koch, Vanguard, or AQR would matter more for SAM than anything in this COCO Form 4.